Definium Therapeutics (DFTX) Stock May Trade Above Fair Value On Book Value

Definium Therapeutics has seen its share price move sharply in recent years, which puts a spotlight on whether the current US$32.97 level is supported by the book value on its balance sheet. With such a strong price story already on the table, investors are asking how much of that journey is reflected in the underlying net assets of the business. Over the past 3 years the stock has delivered a very large gain of about 12x, which puts a lot of pressure on the question of how closely today’s...